35 results
424B4
PPCB
Propanc Biopharma, Inc.
16 Oct 23
Prospectus supplement with pricing info
8:21pm
applications or supplements to approved applications that we submit;
recall of products;
fines, restitution or disgorgement of profits or revenue … result in refusal to approve pending applications, a clinical hold, warning letters, civil or criminal penalties, recall or seizure of products
424B3
v11cq
4 Apr 23
Prospectus supplement
11:22am
424B3
np4ofvi0rvduru
22 Feb 22
Prospectus supplement
11:53am
POS AM
dkbf0xrg70 lm02p
10 Jan 22
Prospectus update (post-effective amendment)
4:46pm
8-K
EX-10.1
7snogbhwmh6mf
3 Apr 20
Entry into a Material Definitive Agreement
5:00pm